Michael A. Greeley MBA

Michael currently serves as a General Partner at Flare Capital Partners. Prior to joining Flare, Michael served as the founding general partner of Flybridge Capital Partners. He also served on the board of International Data Group, the initial flagship Limited Partner for the IDG Ventures global network of funds and Flybridge Capital Partners.

Current and prior board seats include BlueTarp Financial, Explorys, Functional Neuromodulation, Iora Health, MicroCHIPS, Nuvesse, PolyRemedy, Predictive Biosciences, Predilytics, T2 Biosystems, TARIS Biomedical, and VidSys. Previously, Michael focused on emerging-growth company financings with Polaris Partners, was a senior vice president and founding partner of GCC Investments, and held positions at Wasserstein Perella & Co., Morgan Stanley & Co., and Credit Suisse First Boston.

Michael currently serves as chairman of the Entrepreneurship Committee of the Massachusetts Information Collaborative and on the Investment Committee for the Partners Innovation Fund and Massachusetts Eye & Ear Infirmary. Michael also serves on the Industry Advisory Board of the Cleveland Clinic, as well as serving on several other boards including the New England Investors’ Committee of Capital Innovation. He was the former chairman of the New England Venture Capital Association and on the Executive Committee of the board of the National Venture Capital Association. Named by the Boston Globe as the “Go-To” investor for life sciences, healthcare, and medical devices and a Mass High Tech All-Star, Michael earned a B.A. with honors in Chemistry from Williams College and an M.B.A. from Harvard Business School.